Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers from the University of Oxford have today reported findings from a large-scale study that examined the impact of the UK’s MenACWY vaccination programme on the carriage of meningitis bacteria in the throats of UK teenagers. They have demonstrated the impact of the vaccine in generating herd protection, also called herd immunity, that protects all age groups.

Artist's impression of the meningitis bacteria, also known as meningococcus

In the study, which is published in Clinical Microbiology and Infection, the researchers took throat swabs and assessed the prevalence of meningitis causing bacteria before and after the introduction of the vaccination programme, using two cross-sectional studies conducted almost four years apart. They found the vaccine substantially reduced carriage of the W and Y meningococcal groups, and sustained low levels of the C group.

In 2015, responding to rising rates of meningitis cases driven by the W and Y strains from 2009 onwards, the UK replaced a vaccine targeting only the C group (introduced in 1999) with quadrivalent MenACWY vaccines. To leverage herd immunity effects, the vaccination programme enrolled teenagers aged 14 to 19, where transmission of the meningococcal bacteria is known to be highest.

Read the full story on the University of Oxford website

Similar stories

Misophonia: nearly one in five UK adults have the condition causing extreme reactions to certain sounds

Many of us have sounds that we find to be annoying. But for some people, certain sounds actually trigger extreme reactions.

Any type of hormonal contraceptive may increase risk of breast cancer

An analysis of data by researchers at the Nuffield Department of Population Health’s Cancer Epidemiology Unit has shown that use of progestogen-only hormonal contraceptives is associated with a 20-30% higher risk of breast cancer. The results are published in PLOS Medicine.

Viewing self-harm images on the internet and in social media usually causes harm, according to new review

Clinical researchers have reviewed the international research evidence regarding the impact of viewing images of self-harm on the internet and in social media.

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

Athena Swan Gold Award success for Nuffield Department of Primary Care Health Sciences

The award reflects the Department’s commitment to representation, progression and success for all. It acknowledges the innovative policies and practices developed across the department and the detailed action plans for improvement.

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.